AcelRx Pharma (ACRX) Posts Suprise Q3 Profit

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. META
6. SPY
7. BA
8. HOOD
9. INTC
10. JBLU

Go back to AcelRx Pharma (ACRX) Posts Suprise Q3 Profit

Jefferies Asumes, Upgrades AcelRx Pharmaceuticals (ACRX) to Buy

October 30, 2015 7:22 AM EDT

Jefferies assumes, upgraded AcelRx Pharmaceuticals (NASDAQ: ACRX) from Hold to Buy with a price target of $7.00 (from $3.50).

Analyst Hugo Ong commented, "We are upgrading ACRX to a Buy (v. Hold previously) with a $7 PT (v. $3.50 previously), shifting our focus to ARX-04. While... More